mark glatt | Horse Racing Free Tips

Del Mar Futurity Winner Dr. Schivel Victorious In Comeback At Santa Anita

Idle since winning the Grade 1 Del Mar Futurity on Sept. 7, Dr. Schivel overcame significant adversity from his rail post position to win Friday's $65,000 allowance feature by a neck at Santa Anita in Arcadia, Calif. Sold privately prior to the Futurity and running for the first time for trainer Mark Glatt, Dr. Schivel was ridden with confidence by Flavien Prat while getting six furlongs over a track that hadn't been playing overly fast earlier in 1:09.46.

Breaking from the rail, Dr. Schivel was an attentive third, about two lengths off pacesetter Canadian Pride, with three furlongs to run and with the Bob Baffert-trained Speed Pass keeping him hemmed in behind the leader, Prat finally got loose outside of Canadian Pride inside the furlong marker and gradually overhauled him in a thoroughly professional effort.

Off as the 6-5 favorite in a field of five 3-year-olds and up, Dr. Schivel, a Kentucky-bred colt by Violence, paid $4.40, $2.60 and $2.20.

“He broke sharp and then a couple steps outta there, he kinda stutter stepped a little and I think he lost a little bit of early position,” said Glatt. “Those other horses pretty much had him down in a spot there where he was in a lot of trouble, but the most impressive thing was, when Flavien did get him off the inside, and in a place where he could let him run, he said 'You're not beating me.' He came and got that horse.

“A lot of horses at that point, might have said 'Hey, UNCLE for today,' but he just pinned his ears and came after that horse and got him. We've actually been hoping he'd come back and run a race like this in his comeback race. There's a couple races for 3-year-olds at Saratoga in August and we've been planning on getting him back there. That kinda keeps us from stretching him out. There will be a time to stretch him out, but if we can take a shot at a Grade 1 at the end of August for 3-year-olds, that's gonna be right up his alley.”

Owned by Red Baron's Barn, LLC, Rancho Temescal, LLC, William A. Branch and William Dean Reeves, Dr. Schivel is out of the Mining for Money mare Lil Nugget. Originally trained by Luis Mendez, Dr. Schivel improved his overall mark to 5-3-1-1 and with Friday's winning purse of $39,000, increased his earnings to $236,000.

Trained by Peter Eurton, Canadian Pride ran too good to lose, as he did all the early work and finished 5 ¼ lengths in front of Speed Pass. Off at 9-5 with Abel Cedillo, Canadian Pride paid $2.80 and $2.20.

In hot pursuit of the runner-up for five eighths of a mile, Speed Pass, who was off at 7-2 with Edwin Maldonado, paid $2.60 to show while finishing a half length better than Fight On.

Fractions on the race were 22.27, 44.98 and 56.98.

First post time on Saturday, the penultimate day of Santa Anita's 78-day Winter/Spring Meeting is at 1 p.m. PT. Four stakes will highlight an 11-race program.

The post Del Mar Futurity Winner Dr. Schivel Victorious In Comeback At Santa Anita appeared first on Horse Racing News | Paulick Report.

Source of original post

June 18 Insights: Dr. Schivel Returns at Santa Anita

Sponsored by Alex Nichols Agency

4th-SA, $65k, Alw/Opt. Clm, 3yo/up, 6f, 5:31 p.m. ET

DR. SCHIVEL (Violence), a Grade I winner at two, will make his sophomore debut in this allowance/optional claimer sprint Friday at Santa Anita. Placing in a pair of tries to start his career with Beyers of only 57 and 52, the bay jumped way forward with an 86 when romping to a 5 3/4-length graduation last August at Del Mar, a race that included three next-out winners as well as future Grade II victor Spielberg (Union Rags). Bought into by Rancho Temescal and Red Baron's Barn after that effort, he was backed to 7-5 in the GI Runhappy Del Mar Futurity and obliged with a 1 3/4-length success. Transferred from the Luis Mendez barn to Mark Glatt since, Dr. Schivel drew the rail against four rivals in here and shows a lengthy local worktab, highlighted by a five-furlong spin in :59 2/5 (4/61) June 5. TJCIS PPs

—@JBiancaTDN

The post June 18 Insights: Dr. Schivel Returns at Santa Anita appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Bombard Rates Slight Advantage For Saturday’s Daytona Stakes

With a recent race under his belt, Richard Mandella's Bombard perhaps rates a slim advantage over Mark Glatt's comebacking Law Abidin Citizen in Saturday's Grade 3, $100,000 Daytona Stakes at Santa Anita. For older horses, the Daytona has attracted five older horses who will contest 6 ½ furlongs on turf.

A lightly raced 8-year-old gelding by War Front, Bombard led turning for home, but was collared by a razor sharp Gregorian Chant late when second, beaten a half length in a six furlong turf classified allowance here on April 25.

Owned by Perry Bass, Ramona Bass, Adele Dilschneider and Waddell Hancock II, Bombard, although winless in four starts last year, was nonetheless in top form for Mandella, evidenced by a narrow second place finish, beaten a neck, in a Grade III turf sprint at Kentucky Downs Sept. 12 and subsequent 3 ¼ length defeat in the Grade I Breeders' Cup Turf Sprint at Keeneland two starts back on Nov. 7.

With regular rider Flavien Prat back aboard Saturday, Bombard, who is four for nine over the Santa Anita turf, brings an overall mark of 17-5-6-2 and earnings of $399,771.

A graded stakes winner on both turf and dirt, Law Abidin Citizen has been idle since running a close third to top sprinter C Z Rocket in the Grade 2 Pat O'Brien Stakes at Del Mar Aug. 29 and with four wins from nine lifetime starts over the Santa Anita lawn, rates a huge chance with Abel Cedillo back aboard.

A 7-year-old gelding by Twirling Candy, Law Abidin Citizen has tremendous early speed and can be counted upon to press or make the early pace on Saturday. Owned by Dan Agnew, Gerry Schneider and John Xitco, Law Abidin Citizen is 28-7-4-6 overall with earnings of $519,167.

THE GRADE 3 DAYTONA STAKES WITH JOCKEYS & WEIGHTS IN POST POSITION ORDER

Race 5 of 9 Approximate post time 3 p.m. PT

Majestic Eagle—Mario Gutierrez—122
Bombard—Flavien Prat—122
Jamming Eddy—Tyler Baze—120
Law Abidin Citizen—Abel Cedillo—122
Commander—Juan Hernandez—120

First post time for a nine-race card on Saturday is at 1 p.m. For additional information, please visit santaanita.com or call (626) 574-RACE.

The post Bombard Rates Slight Advantage For Saturday’s Daytona Stakes appeared first on Horse Racing News | Paulick Report.

Source of original post

California Horse Racing Board Issues Bisphosphonate Complaint Against Jeff Metz

The California Horse Racing Board issued a complaint against trainer Jeff Metz last week over a finding of bisphosphonates in the Sept. 27, 2020 post-race sample of the gelding Camino De Estrella, reports the Daily Racing Form. The drugs are not yet specifically classified in California, so the positive is being adjudicated under the “prohibited substances” rule with a Class 1, Category A penalty.

However, Metz's attorney Darrell Vienna believes the trainer will be exonerated. Popular at the claim box, Camino de Estrella has been in the care of five different trainers since 2019, including Tim Yakteen, Mark Glatt, Steve Knapp, Metz, and most recently Bill Spawr.

“There is a record of a veterinarian administering the drug when he was not in Mr. Metz's care, in 2019,” Vienna told DRF. “I can say with certainty that Jeff never administered bisphosphonates to that horse. We're confident that the truth will come out, because we think the CHRB already knows the truth.”

Bisphosphonates were approved for equine use in the United States approximately six years ago, to treat horses with symptoms of navicular syndrome, a common, nagging foot pain in older horses. Before the drugs were approved for horses in the U.S., they were used in Europe and veterinarians could legally import them to treat American horses. Having them available to American practitioners who perhaps couldn't previously afford the import process has made a world of difference to mature horses dealing with navicular syndrome – and there are a lot of them. Roughly a third of chronic front leg lamenesses are believed to be related to navicular pain. Generally, bisphosphonates have been safe and effective in the population they're intended for.

Bisphosphonates (sold commercially as Osphos and Tildren) are FDA-approved in horses four years old and up, and are not approved for use in mares who are pregnant or lactating. The reason for those restrictions is unanswered questions about potential side effects. Bisphosphonates do their work by reducing the action of cells called osteoclasts, which clear away damaged bone and make way for osteoblasts to lay down new bone. In a young equine skeleton, this could disrupt the growth cycle.

The CHRB did prohibit the administration of bisphosphonates beginning July 1, 2020, via rule 1867.1, which also prohibits any horse from entering CHRB grounds that has been administered the drug within six months.

Since Camino de Estrella would have been five years old in 2019, administration of a bisphosphonate was legal at that time only if the gelding had a diagnosis of navicular disease.

Vienna argued that “the available science on bisphosphonates clearly demonstrates that the drug can be found more than 2 1/2 years after the drugs have been administered, due to their unique ability to lie dormant in bone but become 'active' in the horse's circulatory system when bone is in need of repair.”